CompuGroup Medical SE & Co. KGaA (LON:0MSD)
22.32
+0.04 (0.18%)
At close: Feb 21, 2025
LON:0MSD Revenue
CompuGroup Medical SE & Co. KGaA had revenue of 290.78M EUR in the quarter ending September 30, 2024, a decrease of -1.15%. This brings the company's revenue in the last twelve months to 1.19B, down -4.63% year-over-year. In the year 2023, CompuGroup Medical SE & Co. KGaA had annual revenue of 1.23B with 4.52% growth.
Revenue (ttm)
1.19B EUR
Revenue Growth
-4.63%
P/S Ratio
n/a
Revenue / Employee
129.30K EUR
Employees
9,199
Market Cap
983.59M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.23B | 53.10M | 4.52% |
Dec 31, 2022 | 1.17B | 112.11M | 10.55% |
Dec 31, 2021 | 1.06B | 193.49M | 22.26% |
Dec 31, 2020 | 869.21M | 98.78M | 12.82% |
Dec 31, 2019 | 770.43M | 34.78M | 4.73% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
GSK plc | 31.38B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
Hikma Pharmaceuticals | 2.39B |
ConvaTec Group | 1.74B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |